CSBR Company Profile and Key Details
Champions Oncology, Inc.
CSBR Stock Price Chart
Stock Price Today
Champions Oncology, Inc. (CSBR) stock surged +1.26%, trading at $10.88 on NASDAQ, up from the previous close of $10.74. The stock opened at $10.74, fluctuating between $10.23 and $10.88 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Company Information
| Employees | 210 |
| Beta | 0.49 |
| Sales or Revenue | $50.16M |
| 5Y Sales Change% | 1.16% |
| Fiscal Year Ends | April |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Champions Oncology, Inc. (NASDAQ: CSBR) stock price is $10.88 in the last trading session. During the trading session, CSBR stock reached the peak price of $10.88 while $10.23 was the lowest point it dropped to. The percentage change in CSBR stock occurred in the recent session was 1.26% while the dollar amount for the price change in CSBR stock was $0.14.
The NASDAQ listed CSBR is part of Biotechnology industry that operates in the broader Healthcare sector. Champions Oncology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David Barry Miller M.B.A.
Chief Financial Officer
Dr. Karin Abarca Heidemann Ph.D.
Executive Vice President of Global Scientific Operations
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG
Executive Vice President of Global Laboratory Operations
Dr. Michael Ritchie M.B.A., Ph.D.
Chief Commercial Officer
Dr. Ronnie Morris M.D.
Pres, Chief Executive Officer & Director
Dr. Maria Mancini Ph.D.
Chief Operating Officer
Dr. Marianna Zipeto Ph.D.
Executive Vice President of Commercial, Research Services & Partnering
CSBR's closing price is 198.33% higher than its 52-week low of $3.60 where as its distance from 52-week high of $11.99 is -10.43%.
Number of CSBR employees currently stands at 210.
Official Website of CSBR is: https://www.championsoncology.com
CSBR could be contacted at phone 201 808 8400 and can also be accessed through its website. CSBR operates from One University Plaza, Hackensack, NJ 07601, United States.
CSBR stock volume for the day was 12.43K shares. The average number of CSBR shares traded daily for last 3 months was 53.13K.
The market value of CSBR currently stands at $150.28M with its latest stock price at $10.88 and 13.82M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com